1 AdAlta Limited (ASX:1AD) ? ABN: 92 120 332 925 ? www.adalta.com.au Suite 1.01, 117 Camberwell Road, Hawthorn East VIC 3123, Australia ASX Announcement | 19 October 2026 AdAlta Limited (ASX:1AD) AdAlta secures Advance Overseas Finding for EW-001 and receives first FY26 R&D Tax Incentive...
RDTI receipt, Advanced Overseas Finding
Filed with ASX · · 3 pages · English
Summary by 6ix AI
The company has already received an initial R&D Tax Incentive instalment for the same financial year, indicating positive cash flow from its R&D investments. AdAlta's CEO highlighted the strategic importance of this finding, which supports their East to West strategy by integrating overseas innovation with Australian capabilities.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Earlier from AdAlta
- EW-001 JDC milestone approvals
- China Representative Office opens
- US FDA grants EW-001 pre-IND meeting
- Oribiotech deal validates AdAlta manufacturing strategy
- BZDS1901 special access scheme launch in China
Follow AdAlta into a list and get an email when it puts out news.
Follow AdAlta